eglobalis
NOVEMBER 3, 2024
This approach has allowed Tetra Pak to work closely with clients in diverse sectors, from food production to pharmaceuticals, ensuring each solution aligns with their unique needs and priorities. Measure What Matters and Getting Clarity Traditional metrics often fall short in fully capturing the effectiveness of personalized CX strategies.
Beyond Philosophy
OCTOBER 19, 2016
More organizations call our Customer Experience consultancy every day with the same complaint: they aren’t seeing the same gains in Net Promoter Score (NPS) that they did when they started their Customer Experience Improvement program. Old Thinking Doesn’t Work with New Problems. They want to know what to do now.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Beyond Philosophy
DECEMBER 11, 2020
In other words, the feeling you want to evoke should give you some payback, whether that’s revenue, retention, or an increase in Net Promoter Score®. Ideally, these emotions drive value. Any time we veer into the area of emotions, we kind of get to this “squishy” area of psychology and intangibles.
PeopleMetrics
JANUARY 18, 2022
For example, pharmaceutical companies have very unique customer experience needs that aren’t well supported by generic software. Both benefits help you grow your net promoter scores and customer retention metrics without sacrificing all of your team’s time and attention to inefficient, unscalable processes.
Intercom, Inc.
FEBRUARY 15, 2018
It’s so funny how much businesses talk about the net promoter score, which is how likely are you to recommend this to a friend, but they don’t name products or services or pricing tiers to help people do that. If you say it out loud, it sounds like a pharmaceutical name that nobody could ever remember.
Execs In The Know
FEBRUARY 28, 2025
McKinsey’s research shows process-first implementations deliver 40% faster clinical trial approvals in pharmaceutical settings and similar efficiency gains across industries [9]. The Risk-Based Implementation Framework Not all processes are created equal when it comes to GenAI implementation.
Execs In The Know
FEBRUARY 28, 2025
McKinsey’s research shows process-first implementations deliver 40% faster clinical trial approvals in pharmaceutical settings and similar efficiency gains across industries [9]. The Risk-Based Implementation Framework Not all processes are created equal when it comes to GenAI implementation.
Expert insights. Personalized for you.
523 
Let's personalize your content